Nephrocystin 1

Alternative Names

  • NPHP1
  • NPH1
Back to search Result
OMIM Number

607100

NCBI Gene ID

4867

Uniprot ID

O15259

Length

82,756 bases

No. of Exons

23

No. of isoforms

4

Protein Name

Nephrocystin-1

Molecular Mass

83299 Da

Amino Acid Count

732

Genomic Location

chr2:110,122,311-110,205,066

Gene Map Locus
2q13

Description

This gene encodes a protein with src homology domain 3 (SH3) patterns. This protein interacts with Crk-associated substrate, and it appears to function in the control of cell division, as well as in cell-cell and cell-matrix adhesion signaling, likely as part of a multifunctional complex localized in actin- and microtubule-based structures. Mutations in this gene cause familial juvenile nephronophthisis type 1, a kidney disorder involving both tubules and glomeruli. Defects in this gene are also associated with Senior-Loken syndrome type 1, also referred to as juvenile nephronophthisis with Leber amaurosis, which is characterized by kidney and eye disease, and with Joubert syndrome type 4, which is characterized by cerebellar ataxia, oculomotor apraxia, psychomotor delay and neonatal breathing abnormalities, sometimes including retinal dystrophy and renal disease. Multiple transcript variants encoding different isoforms have been found for this gene. [From RefSeq]

Molecular Genetics

 

 

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NPHP1, DELLebanonPathogenicPathogenicJoubert Syndrome 43511

Other Reports

Egypt

By using a multiplex PCR approach, Soliman et al. (2010) investigated the prevalence of the homozygous NPHP1 deletion among a cohort of 20 children from 17 independent Egyptian families who met the clinical and ultrasonographic criteria of nephronophthisis. Seventy-five percent of the studied patients were the products of consanguineous marriages, the percentage of affected siblings was strikingly high (65%, 13/20 patients), and 40% (8/20 patient) had a history of sibling death due to a similar condition. Soliman et al. (2010) reported that homozygous deletions in the NPHP1 gene were identified in six patients from five independent families of 17 families studied (29.4%), thereby confirming the diagnosis of type 1 (juvenile) nephronophthisis. Five patients had isolated nephronophthisis, whereas the sixth patient was among the Joubert syndrome-related disorders (JSRD) group, with distinct molar tooth sign detected on his brain MRI images, ataxia, retinitis pigmentosa, and dysmorphic facies. These findings led Soliman et al. (2010) to confirm that NPHP1 deletions can indeed be responsible for JSRD, as previously reported. Soliman et al. (2010) also documented the first report of a homozygous NPHP1 deletion in an infantile-onset nephronophthisis patient in whom the clinical manifestations began in the first year of life and progressed to End Stage Renal Disease (ESRD) by the age of 32 months. Soliman et al. (2010) concluded that the prevalence of homozygous deletions in the NPHP1 gene does not seem to differ in Egypt from that reported in Western countries.

Saudi Arabia

Al-Romaih et al. (2011) studied two unrelated Saudi families with family histories of proteinuria, end stage renal disease, and various findings on kidney biopsy.  The diagnosis was initially thought to be focal segmental glomerulosclerosis (FSGS).  Sequencing analysis failed to identify the underlying genetic defects in nephrotic syndrome and FSGS genes.  Both families shared a region of homozygosity on chromosome 2q13 based on Whole-genome SNP analysis and homozygosity mapping.  Al-Romaih et al. (2012) identified a homozygous deletion of NPHP1 using polymerase chain reaction assay and exome sequencing. 

© CAGS 2024. All rights reserved.